Kedrion Biopharma, Secondary Immunodeficiency, Primary Immunodeficiency, ESID 2026, Immunoglobulin Therapy, Immune System, Early Diagnosis, Immunology Research, Patient Awareness

Maastricht, Netherlands, October 14, 2026 Kedrion Biopharma has joined physicians, researchers and patient advocacy organizations in calling for earlier...